Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.21.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Non-controlling Interest
Common stock, shares issued, beginning balance (in shares) at Dec. 31, 2019     66,320,706 (13,479,000)            
Balance, at period start at Dec. 31, 2019 $ 867,576 $ (1,141) $ 331 $ (90,965) $ 1,037,141   $ (1,749) $ (75,664) $ (1,141) $ (1,518)
Increase (decrease) in shareholders' equity                    
Exercise of stock options (in shares)     357,974              
Exercise of stock options 3,408   $ 2   3,406          
Issuance of common stock - vesting of restricted stock units (in shares)     398,881              
Issuance of common stock - vesting of restricted stock units 2   $ 2              
Stock-based compensation expense 13,765       13,765          
Shares withheld to satisfy tax withholdings (in shares)       (130,164)            
Shares withheld to satisfy tax withholdings (9,199)     $ (9,199)            
Foreign currency translation gains (losses), net of taxes (3,024)           (3,024)      
Net income (loss) (7,190)             (7,336)   146
Common stock, shares issued ending balance (in shares) at Mar. 31, 2020     67,077,561 (13,609,164)            
Balance, at period end at Mar. 31, 2020 864,197   $ 335 $ (100,164) 1,054,312   (4,773) (84,141)   (1,372)
Common stock, shares issued, beginning balance (in shares) at Dec. 31, 2019     66,320,706 (13,479,000)            
Balance, at period start at Dec. 31, 2019 867,576 (1,141) $ 331 $ (90,965) 1,037,141   (1,749) (75,664) (1,141) (1,518)
Increase (decrease) in shareholders' equity                    
Foreign currency translation gains (losses), net of taxes (1,449)                  
Transfer of non-controlling units 771                  
Net income (loss) (12,661)                  
Common stock, shares issued ending balance (in shares) at Jun. 30, 2020     67,396,243 (13,652,861)            
Balance, at period end at Jun. 30, 2020 873,737   $ 337 $ (103,781) 1,071,502   (3,198) (89,065)   (2,058)
Common stock, shares issued, beginning balance (in shares) at Dec. 31, 2019     66,320,706 (13,479,000)            
Balance, at period start at Dec. 31, 2019 $ 867,576 (1,141) $ 331 $ (90,965) 1,037,141   (1,749) (75,664) (1,141) (1,518)
Increase (decrease) in shareholders' equity                    
Accounting Standards Update [Extensible List]                    
Common stock, shares issued ending balance (in shares) at Dec. 31, 2020 67,832,706   67,832,706 (13,739,171)            
Balance, at period end at Dec. 31, 2020 $ 975,818 (79,842) $ 339 $ (110,466) 1,166,774 $ (108,470) (398) (79,912) 28,628 (519)
Common stock, shares issued, beginning balance (in shares) at Mar. 31, 2020     67,077,561 (13,609,164)            
Balance, at period start at Mar. 31, 2020 864,197   $ 335 $ (100,164) 1,054,312   (4,773) (84,141)   (1,372)
Increase (decrease) in shareholders' equity                    
Exercise of stock options (in shares)     184,475              
Exercise of stock options 3,275   $ 1   3,274          
Issuance of common stock - vesting of restricted stock units (in shares)     134,207              
Issuance of common stock - vesting of restricted stock units 1   $ 1              
Stock-based compensation expense 13,006       13,006          
Shares withheld to satisfy tax withholdings (in shares)       (43,697)            
Shares withheld to satisfy tax withholdings (3,617)     $ (3,617)            
Foreign currency translation gains (losses), net of taxes 1,575           1,575      
Transfer of non-controlling units 771       910         (139)
Net income (loss) (5,471)             (4,924)   (547)
Common stock, shares issued ending balance (in shares) at Jun. 30, 2020     67,396,243 (13,652,861)            
Balance, at period end at Jun. 30, 2020 $ 873,737   $ 337 $ (103,781) 1,071,502   (3,198) (89,065)   (2,058)
Common stock, shares issued, beginning balance (in shares) at Dec. 31, 2020 67,832,706   67,832,706 (13,739,171)            
Balance, at period start at Dec. 31, 2020 $ 975,818 (79,842) $ 339 $ (110,466) 1,166,774 (108,470) (398) (79,912) 28,628 (519)
Increase (decrease) in shareholders' equity                    
Exercise of stock options (in shares)     27,043              
Exercise of stock options 522       522          
Issuance of common stock - vesting of restricted stock units (in shares)     455,349              
Issuance of common stock - vesting of restricted stock units 2   $ 2              
Stock-based compensation expense 14,013       14,013          
Shares withheld to satisfy tax withholdings (in shares)       (147,041)            
Shares withheld to satisfy tax withholdings (9,541)     $ (9,541)            
Share repurchase (in shares)       (24,227)            
Share repurchase (1,672)     $ (1,672)            
Foreign currency translation gains (losses), net of taxes (624)           (624)      
Other 118                 118
Net income (loss) 14,935             14,946   (11)
Common stock, shares issued ending balance (in shares) at Mar. 31, 2021     68,315,098 (13,910,439)            
Balance, at period end at Mar. 31, 2021 $ 913,729   $ 341 $ (121,679) 1,072,839   (1,022) (36,338)   (412)
Common stock, shares issued, beginning balance (in shares) at Dec. 31, 2020 67,832,706   67,832,706 (13,739,171)            
Balance, at period start at Dec. 31, 2020 $ 975,818 $ (79,842) $ 339 $ (110,466) 1,166,774 $ (108,470) (398) (79,912) $ 28,628 (519)
Increase (decrease) in shareholders' equity                    
Exercise of stock options (in shares) 31,125                  
Foreign currency translation gains (losses), net of taxes $ (1,888)                  
Transfer of non-controlling units 0                  
Net income (loss) $ 6,566                  
Common stock, shares issued ending balance (in shares) at Jun. 30, 2021 68,459,262   68,459,262 (13,963,399)            
Balance, at period end at Jun. 30, 2021 $ 917,466   $ 342 $ (125,583) 1,089,263   (2,286) (44,619)   349
Common stock, shares issued, beginning balance (in shares) at Mar. 31, 2021     68,315,098 (13,910,439)            
Balance, at period start at Mar. 31, 2021 913,729   $ 341 $ (121,679) 1,072,839   (1,022) (36,338)   (412)
Increase (decrease) in shareholders' equity                    
Exercise of stock options (in shares)     4,082              
Exercise of stock options 51       51          
Issuance of common stock - vesting of restricted stock units (in shares)     140,082              
Issuance of common stock - vesting of restricted stock units 1   $ 1              
Stock-based compensation expense 17,161       17,161          
Shares withheld to satisfy tax withholdings (in shares)       (46,699)            
Shares withheld to satisfy tax withholdings (3,479)     $ (3,479)            
Share repurchase (in shares)       (6,261)            
Share repurchase (425)     $ (425)            
Foreign currency translation gains (losses), net of taxes (1,264)           (1,264)      
Other 38                 38
Capital contribution - non-controlling interest 23       (788)         811
Net income (loss) $ (8,369)             (8,281)   (88)
Common stock, shares issued ending balance (in shares) at Jun. 30, 2021 68,459,262   68,459,262 (13,963,399)            
Balance, at period end at Jun. 30, 2021 $ 917,466   $ 342 $ (125,583) $ 1,089,263   $ (2,286) $ (44,619)   $ 349